RESUMEN
The role of the advanced practice nurse in nephrology is evolving rapidly. The following questions and role descriptions were posted on the ANNAlink Advanced Practice ListServe. The dialogue is just beginning--stay tuned! Stay informed and connect to advance your practice!
Asunto(s)
Actitud del Personal de Salud , Nefrología , Enfermeras Clínicas/psicología , Enfermeras Practicantes/psicología , Rol de la Enfermera/psicología , Certificación , Educación de Postgrado en Enfermería , Humanos , Satisfacción en el Trabajo , Fallo Renal Crónico/enfermería , Enfermeras Clínicas/educación , Enfermeras Clínicas/organización & administración , Enfermeras Practicantes/educación , Enfermeras Practicantes/organización & administración , Diálisis Renal/enfermeríaAsunto(s)
Población Negra , Supervivencia de Injerto , Terapia de Inmunosupresión/métodos , Trasplante de Riñón/fisiología , Adulto , Negro o Afroamericano , Ciclosporina/uso terapéutico , Femenino , Estudios de Seguimiento , Rechazo de Injerto/epidemiología , Prueba de Histocompatibilidad , Humanos , Inmunosupresores/uso terapéutico , Trasplante de Riñón/inmunología , Masculino , Metilprednisolona/uso terapéutico , Análisis Multivariante , Prednisona/uso terapéutico , Estudios Retrospectivos , Medición de Riesgo , Factores de Tiempo , Estados Unidos , Población BlancaRESUMEN
African Americans (AA) have traditionally been thought to have higher immunologic risk than Caucasians (CA) for rejection and allograft loss. The impact of ethnicity on the outcome of simultaneous pancreas-kidney (SPK) transplant with basiliximab induction has not been reported. In this study, we retrospectively analyze the long-term results of 36 AA and 55 CA recipients of primary SPK. The actual patient survival rates of AA and CA groups were 91.7% vs. 90.1% at 1 year, 93.3% vs. 88.1% at 3 years, and 94.4% vs. 83.3% at 5 years. The actual kidney survival of AA and CA were 91.7% vs. 89.1% at 1 year, 90% vs. 81% at 3 years, and 83.3% vs. 75% at 5 years. The actual pancreas survival of AA and CA were 88.9% vs. 85.5% at 1 year, 83.3% vs. 78.6% at 3 years and 72.2% vs. 70.8% at 5 years. Death-censored analyses also found no difference in pancreas and kidney graft survival rates over 5 years. Higher rejection rate, but the same low CMV infection, and comparable quality of graft function were noted in AA group. AA may not have worse long-term outcomes than CA recipients of SPK with basiliximab induction and tacrolimus (TAC), mycophenolate acid (MFA) and steroid maintenance immunotherapy.
Asunto(s)
Anticuerpos Monoclonales/uso terapéutico , Población Negra/estadística & datos numéricos , Inmunosupresores/uso terapéutico , Trasplante de Riñón/inmunología , Trasplante de Páncreas/inmunología , Proteínas Recombinantes de Fusión/uso terapéutico , Población Blanca/estadística & datos numéricos , Basiliximab , Estudios de Seguimiento , Rechazo de Injerto/epidemiología , Rechazo de Injerto/mortalidad , Humanos , Trasplante de Riñón/mortalidad , Louisiana , Trasplante de Páncreas/mortalidad , Estudios Retrospectivos , Factores de Riesgo , Análisis de Supervivencia , Sobrevivientes , Factores de TiempoRESUMEN
For patients with end-stage renal disease (ESRD) whose anemia is corrected with Epoetin alfa, a higher hematocrit typically results in increased well-being and renewed interest in life, including sexual activity. Paradoxically, this generally positive therapeutic outcome can result in sexual problems for the patient and his or her partner because of changing expectations. Understanding the physical and psychosocial causes of sexual dysfunction in patients with ESRD, as well as strategies for assessment and intervention, prepares nurses to anticipate sexual problems and intervene appropriately.
Asunto(s)
Eritropoyetina/uso terapéutico , Fallo Renal Crónico/tratamiento farmacológico , Fallo Renal Crónico/psicología , Disfunciones Sexuales Psicológicas/psicología , Adulto , Eritropoyetina/farmacología , Humanos , Masculino , Disfunciones Sexuales Psicológicas/enfermeríaRESUMEN
This article reviews the anatomy and physiology of the male reproductive system and pathophysiology attributed to chronic renal disease. Clinical evaluation strategies are outlined and treatment modalities explained. The role of the nephrology nurse is outlined as a patient advocate and advisor.
Asunto(s)
Fallo Renal Crónico/complicaciones , Disfunciones Sexuales Fisiológicas , Humanos , Masculino , Disfunciones Sexuales Fisiológicas/diagnóstico , Disfunciones Sexuales Fisiológicas/enfermería , Disfunciones Sexuales Fisiológicas/terapiaRESUMEN
BACKGROUND: The association between cyclosporine (CsA) and thrombotic microangiopathy (TMA) in renal allografts is well documented. However, predisposing factors and therapy guidelines are not adequately characterized. METHODS: We reviewed 188 patients with kidney or kidney-pancreas transplants who were treated between January 1994 and December 1996 with prednisone, CsA, or tacrolimus, and azathioprine or mycophenolate. We analyzed 50 patients who had graft biopsies: 26 with TMA and 24 with no TMA, as well as 19 patients with well-functioning grafts who never required biopsy. RESULTS: TMA was observed in 26 of 188 renal graft recipients (14%). TMA was confined to the allograft kidney without any systemic evidence in 24 of the 26 patients. At the time of the diagnosis of TMA, 24 of the patients were on CsA, with 19 on the microemulsion form. Conversely, 5 of 18 control patients with no graft dysfunction were on the microemulsion form of CsA (P = 0.0026). Graft loss was seen in 8 of 26 patients with TMA. Conversion from CsA to tacrolimus resulted in a one-year salvage of graft function in 13 of 16 (81%) patients. CONCLUSIONS: TMA was the cause of renal graft dysfunction in 14% of renal graft recipients and was associated with the use of the microemulsion form of CsA. Systemic signs of TMA were rare, underscoring the importance of the graft biopsy in making the diagnosis. The most successful strategy was switching from CsA to tacrolimus, with good graft function in 81% of the recipients one year after the TMA episode.
Asunto(s)
Ciclosporina/efectos adversos , Inmunosupresores/efectos adversos , Enfermedades Renales/etiología , Trasplante de Riñón/efectos adversos , Trombosis/etiología , Adolescente , Adulto , Estudios de Casos y Controles , Femenino , Rechazo de Injerto/tratamiento farmacológico , Rechazo de Injerto/patología , Rechazo de Injerto/fisiopatología , Humanos , Enfermedades Renales/patología , Enfermedades Renales/fisiopatología , Trasplante de Riñón/patología , Trasplante de Riñón/fisiología , Masculino , Persona de Mediana Edad , Tacrolimus/uso terapéutico , Trombosis/patología , Trombosis/fisiopatologíaRESUMEN
We reviewed our initial experience with helical computed tomography (CT) angiography in the evaluation of living kidney donors which, until now, has necessitated arteriography. Nineteen donors (12 women, 7 men) have had their renal anatomy evaluated solely by CT angiography preoperatively. All scans demonstrated normal collecting systems and single ureters. Five donors (26%) had supernumerary renal arteries. Fourteen donors had single, 4 donors had two, and 1 donor had three renal arteries. Helical CT demonstrated small polar vessels in several donors. Two donors (10%) had supernumerary renal veins. Accuracy of vascular anatomy defined on CT was 90% when confirmed at operation. Anatomically all CT findings were consistent with operative findings except in 1 donor who was found to have a 0.8 cm lesion near the renal hilum. At our institution, the total charges for selective renal arteriography are $3845 and for helical CT with three-dimensional (3-D) reconstruction are $1546. The amount of contrast dye (approximately 100 mL) is equivalent. Patients uniformly reported that the CT scan was a convenient and painless procedure. The accuracy of helical CT angiography is equivalent to arteriography in assessing renal vascular anatomy (with the additional benefit of imaging venous and parenchymal anatomy). Charges for helical CT are 59% less. There is greater patient acceptance and potentially less morbidity associated with the non-invasive nature of helical CT. We believe that CT angiography is the radiologic procedure of choice for the assessment of renal anatomy in potential living kidney donors.
Asunto(s)
Trasplante de Riñón , Donadores Vivos , Arteria Renal/diagnóstico por imagen , Tomografía Computarizada por Rayos X , Adulto , Femenino , Humanos , Procesamiento de Imagen Asistido por Computador , MasculinoRESUMEN
In a pediatric renal transplant program that actively seeks living-related kidney donors, we achieved a living donor rate of 55% in 119 children. This approximates the national average but is less than an idealized goal. For black children, the living-donor transplant rate was 41%, a disconcertingly low rate. In an attempt to define factors that negatively affected living-related donor availability, we analyzed our evaluation process by distinct phases (interview, histocompatibility testing and medical evaluation). We classified our families on the basis of locale (urban, suburban and rural), family unit (two or less parents, adult sibs or other relatives presenting at interview) and economic status (designating only economic-disadvantaged and other). While histoincompatibility is predictably a negative factor, the negative impacts of medical illness in the donor pool, economic disadvantage and single parent family are striking and cumulative. Our data validate the relative success of an aggressive recruitment policy in a patient population that includes many economically disadvantaged families. For pediatric renal transplant programs with low living-related donor rates, our data should encourage review and possible modification of the donor recruitment process.
Asunto(s)
Fallo Renal Crónico/cirugía , Trasplante de Riñón , Donadores Vivos/estadística & datos numéricos , Adulto , Negro o Afroamericano , Niño , Familia , Humanos , Factores Socioeconómicos , Obtención de Tejidos y Órganos/métodos , Estados UnidosRESUMEN
Rupture of a renal allograft (RAR) is an uncommon but serious complication of renal transplantation. A recent RAR prompted a review of our experience, with the purpose of (1) identifying conditions that may predispose this complication and (2) defining strategies for prevention. A 5-yr, consecutive living-related (LRD) and cadaver donor (CD) cohort of 331 patients was studied retrospectively. Twelve patients (3.6%) had RAR. Donor characteristics, procurement and preservation conditions, and recipient characteristics were major study categories. Data analysis was computer-based and included multivariate analysis. The nine White and two Black cadaver donors were "ideal", mean age 29 yr, with mean high creatinine (CR) of 1.3 and terminal CR of 1.1 mg/dl and mean terminal urine output of 423 ml/min. Nine of 11 CD had low-dose dopamine use (terminal, mean 8, range 5-13 micrograms/kg/min). Eleven of 11 donors had procurement en-bloc, 9 of which were multiple organ procurement. All had 4+/4+ flush and cold storage with UW solution. Mean cold ischemia time (CIT) was 22 h, 28 min (range 15 h, 16 min to 40 h). For patients with RAR mean age was 39 yr; there were 12 Black patients and 7 males, 5 females. HLA match was 1 antigen (AG) for 3, 2 AG for 8, and 4 AG for 1 (mean 1.9). Nine patients had delayed or declining renal function requiring dialysis. The panel reactive antibody was at peak, mean 47% (range 0-100%) and current, mean 18% (range 0-84%). Six of 12 had OKT3 therapy at time of RAR and six had biopsies. Day of RAR was mean 10, median 9 (range 4-21). Pain and drop in hematocrit were observed in most. There was one fatality (8%), and all kidneys were removed. All kidneys showed at least minimal rejection but six had severe acute tubular necrosis (ATN) with edema and minimal rejection. Statistically significant associations with RAR were older recipient age (p = 0.01), donor-recipient race mismatch (White donor to Black recipient) (p = 0.007), and dialysis requirement (p < 0.001). Other variables were not statistically correlated: gender, race, CIT, transplant number, LRD vs. CD, peak or current PRA, and total HLA and BDR mismatch. The data suggest that ATN and rejection act synergistically to cause RAR and that early delayed function requires intensive and perhaps novel immunosuppression, especially in Black recipients.